Access cutting-edge lupus nephritis treatment through this clinical trial at a research site in Stanford. Study-provided care at no cost to qualified participants.
Access lupus nephritis specialists in Stanford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lupus nephritis treatment provided free
In this study, researchers will learn more about the use of felzartamab in people with active lupus nephritis, also known as LN. In people with LN, antibodies build up in the glomeruli of the kidneys. Antibodies are proteins in the blood used by the immune system to fight infection. Glomeruli are small filters that remove waste and extra fluid from the blood. This buildup leads to inflammation and damage to the kidneys. Kidney damage can lead to too much protein and blood leaking into the urine
Sponsor: HI-Bio, A Biogen Company
Check if you qualify for this lupus nephritis clinical trial in Stanford, CA
If you're searching for lupus nephritis treatment options in Stanford, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Stanford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lupus nephritis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.